Your browser doesn't support javascript.
loading
PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson's Disease.
Yu, Seong-Jin; Chen, Shuchun; Yang, Yung-Yung; Glotfelty, Elliot J; Jung, Jin; Kim, Hee Kyung; Choi, Ho-Il; Choi, Doo-Sup; Hoffer, Barry J; Greig, Nigel H; Wang, Yun.
Afiliación
  • Yu SJ; Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taiwan.
  • Chen S; Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taiwan.
  • Yang YY; Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taiwan.
  • Glotfelty EJ; Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, United States.
  • Jung J; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Kim HK; Peptron Inc., Daejeon, South Korea.
  • Choi HI; Peptron Inc., Daejeon, South Korea.
  • Choi DS; Peptron Inc., Daejeon, South Korea.
  • Hoffer BJ; Departments of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.
  • Greig NH; Department of Neurosurgery, Case Western Reserve University School of Medicine, Cleveland, OH, United States.
  • Wang Y; Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, United States.
Front Neurosci ; 14: 785, 2020.
Article en En | MEDLINE | ID: mdl-32848559

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2020 Tipo del documento: Article